Richard Hatchett is an American oncologistEric Lipton and Jennifer Steinhauer (April 22, 2020), The Untold Story of the Birth of Social Distancing New York Times. and epidemiologist who has been chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI) in Oslo and London since 2017.Andrew Jack (April 19, 2017), Partnership of nations set to combat pandemic health threats Financial Times. He was awarded the Secretary of Health and Human Services's Award for Distinguished Service.

Early life and education Hatchett grew up in Alabama.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine. He graduated from Vanderbilt University and Vanderbilt University School of Medicine.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine. He completed an internship and residency in Internal Medicine at New York Hospital – Cornell Medical Center, and a fellowship in Medical Oncology at the Duke University Hospital.Dr Richard Hatchett offered position as permanent CEO of CEPI Coalition for Epidemic Preparedness Innovations (CEPI), press release of February 28, 2017. He was also a research associate at the National Heart & Lung Institute at Imperial College London and spent three months in northeast Gabon investigating three closely related Ebola outbreaks.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine.

Career Early career In 2001, Hatchett worked as an attending in the urgent care center at Memorial Sloan Kettering Cancer Center in New York City and was planning to start an oncology fellowship in the summer of 2002.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine. In the immediate aftermath of the September 11 attacks, he volunteered at the World Trade Center site.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine. He subsequently moved to Washington, D.C. to help set up the new Medical Reserve Corps (MRC) in 2002.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine.

Career in government From 2005 until 2006, Hatchett was Director for Biodefense Policy on the United States Homeland Security Council and was a principal author of the National Strategy for Pandemic Influenza Implementation Plan.Dr Richard Hatchett offered position as permanent CEO of CEPI Coalition for Epidemic Preparedness Innovations (CEPI), press release of February 28, 2017. He was also on a pandemic planning team, under President George W. Bush. In this capacity, he devised the concept of social distancing as a non-pharmaceutical intervention intended to prevent the spread of a contagious disease.Eric Lipton and Jennifer Steinhauer (April 22, 2020), The Untold Story of the Birth of Social Distancing New York Times.

From 2005 until 2011, Hatchett was associate director for Radiation Countermeasures Research and Emergency Preparedness at the National Institute of Allergy and Infectious Diseases (NIAID), under the leadership of Anthony Fauci.Dr Richard Hatchett offered position as permanent CEO of CEPI Coalition for Epidemic Preparedness Innovations (CEPI), press release of February 28, 2017. In 2007, he was the lead author of a study in Proceedings of the National Academy of Sciences of the United States of America comparing public-health responses to the Spanish flu in cities like St. Louis and Philadelphia.Nicholas Bakalar (April 17, 2007), How (and How Not) to Battle Flu: A Tale of 23 Cities New York Times. He also advised on the US government's handling of the 2009 swine flu pandemic.Andrew Jack (April 19, 2017), Partnership of nations set to combat pandemic health threats Financial Times.

In addition to his role at NIAID, Hatchett was Director for Medical Preparedness Policy on the Homeland Security Council under President Barack Obama from 2009 until 2011.

Hatchett was the Chief Medical Officer and deputy director of the United States Biomedical Advanced Research and Development Authority (BARDA) from 2011 to 2016 before becoming the organization's acting Director in 2016. At BARDA, he oversaw programs to develop medical countermeasures against chemical, biological, radiological and nuclear threats, pandemic influenza, and emerging infectious diseases and led or helped lead the development of vaccines, therapeutics and diagnostics for a number of emerging viruses, including the H3N2v and H7N9 influenza viruses, MERS, Ebola and Zika.Kathy Whitney (March 19, 2021), Alumni Profile: Richard Hatchett, MD’95, BA’89 Vanderbilt University School of Medicine.

CEO of CEPI, 2017–present In 2017, Hatchett was appointed as CEO of the Coalition for Epidemic Preparedness Innovations, succeeding interim CEO John-Arne Røttingen.Dr Richard Hatchett offered position as permanent CEO of CEPI Coalition for Epidemic Preparedness Innovations (CEPI), press release of February 28, 2017. In May 2020, amid the COVID-19 pandemic, he was appointed to the expert advisory group for the UK Government's Vaccine Task Force.Funding and manufacturing boost for UK vaccine programme Government of the United Kingdom, press release of May 17, 2020. When the UK held the rotating presidency of the Group of Seven (G7) in 2021, the government also appointed him as a member of the Pandemic Preparedness Partnership, chaired by Patrick Vallance.

Under Hatchett's leadership, CEPI funded early development of COVID-19 candidate vaccines. CEPI also teamed up with the African Union to fund African vaccine production. Together with Seth Berkley, he developed the concept for COVAX in early 2020.Stephanie Baker and James Paton (3 June 2021), The World's Best Hope to End the Pandemic Still Needs More Doses Bloomberg Businessweek. CEPI is organizing a 2022 Covid summit.

In March 2020, Hatchett warned about COVID-19. He does not think Intellectual property rights significantly contribute to vaccine shortages. He is concerned about supply chain problems, and export controls.

References

External links

https://cepi.net/about/whoweare/ Interview with Richard Hatchett International Finance Corporation, October 2020